Scientists from the Gladstone Institute of Virology and Immunology (GIVI) and the National Institutes of Allergy and Infectious Diseases (NIAID) have identified a gene that may influence the production of antibodies that neutralize HIV. This discovery is likely to lead ...
2008 Nobel Prize in Medicine
The Nobel Assembly at Karolinka Institute is awarding the 2008 Nobel Prize in Physiology or Medicine to Harald zur Hausen of the German Cancer Research Centre in Heidelberg, Germany, Francoise Barre-Sinoussi of the Virology Department of the Institut Pasteur in ...
The Exercise Pill
If you don’t like exercising you’re definitely not alone in your aversion. However, soon there may be a solution for you – in a form of a pill. Scientists from the Salk institute for Biological studies in California have developed ...
Vena Platform
Cambridge Consultants, as part of the Continua Health Alliance, has announced the development of the Vena platform. Vena is a single-chip communications solution for health devices, with the capability to provide wired (USB) and wireless (Bluetooth) connectivity to health devices. ...
New Treatment Halts Progress of Alzheimer’s
Pioneering research by UK scientists shows that a new product – Rember – may slow the progress of mild to moderate Alzheimer’s disease by 81% over a year and could offer hope to millions worldwide. Rember is the first drug ...
The Link Between Stress and Illness
Do you like being under pressure? Do you enjoy running around like a mouse on a wheel? Think again. Scientists from UCLA have discovered a cellular mechanism linking between stress, aging, and illness. This discovery could potentially help create drugs ...
Insulin Nanopump for Accurate Drug Delivery
The Swiss Company Debiotech has developed a tiny insulin pump to deliver accurate drug quantities over a long time. The pump, 65 millimeters in size, sucks the drug from a container and injects it to the body. The device is ...
From Allergy to Alzheimer’s Treatment
The San Francisco based biopharmaceutical company Medivation has recently published results of its first pivotal clinical trial of Dimebon in Alzheimer’s disease. Dimebon, a drug formerly approved as an allergy treatment, demonstrated statistically significant improvement over placebo in memory, thinking, ...
Spectroscopy Finds Early Tooth Decay
King’s College, London is developing a new technology that may make the dentist’s drill obsolete in as little as five years. A preliminary study shows that decay causing bacteria scatter light differently from healthy tooth matter. Using a form of ...
Microtags Make MRI ’See’ in Color
Scientists from the National Institute of Standards and Technology (NIST) and the National Institutes of Health (NIH) have developed customized microscopic magnets called microtags that might one day be injected into the body and make magnetic resonance imaging (MRI) colorful. ...